Prana Biotechnology Limited (PBT.AX)

ASX - ASX Delayed Price. Currency in AUD
0.10-0.00 (-1.87%)
At close: 2:10 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.11
Bid0.10 x
Ask0.11 x
Day's Range0.10 - 0.11
52wk Range0.06 - 0.15
1y Target EstN/A
Market Cap56.06M
P/E Ratio (ttm)-7.50
Avg Vol (3m)174,666
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Business Wire2 months ago

    Prana Alzheimer's disease data features at world leading conference

    Professor Rudolph Tanzi, Founding Scientist and Chief Scientific Advisor for Prana Biotechnology, presented results obtained from testing PBT2, Prana’s lead candidate for Huntington and Alzheimer’s diseases, at the Alzheimer’s Association International Conference in Toronto, Canada on July 26, 2016.

  • Five Stocks on the Move Today Amid a Mixed Market
    Insider Monkey3 months ago

    Five Stocks on the Move Today Amid a Mixed Market

    The US stock market is mixed, but relatively flat on Wednesday, following Federal Reserve Chairwoman Janet Yellen’s dovish message on interest rates, and ahead of tomorrow’s Brexit vote, which now seems like it will resolve toward a “Stay”. Among individual stocks, Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Michael Kors Holdings Ltd (NYSE:KORS), Advanced Micro Devices, Inc. […]

  • Business Wire5 months ago

    Prana Regains Compliance with NASDAQ Continued Listing Requirements Continues to Work Towards FDA Submission

    Prana Biotechnology Ltd today announced that it has received a notice dated April 8th 2016 from the Listing Qualifications Department of NASDAQ Stock Market Inc.